Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination 
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off 
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program 
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
NASA and Roscosmos Chiefs Meet in Florida to Discuss Moon and ISS Cooperation 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election 
Oil Prices Slide on US-Iran Talks, Dollar Strength and Profit-Taking Pressure 
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
The Korea Photonics Technology Institute has developed a free-space augmented reality (AR) system that allows examination of breast cancer tissue’s location and shape through the naked eye.
The system, developed in collaboration with the institution, local AR developer Apros Corp., and the National Cancer Center, uses a small light projection device to broadcast a video of breast cancer captured by a camera onto the afflicted region for surgeons.
The near-infrared fluorescence probe video system that is typically used for breast cancer surgery does not allow surgeons to see the wavelength of the light generated by the fluorescent contrast agent with their naked eyes, necessitating the use of a separate monitor with a dedicated camera for the surgery.
The innovative method reflects real-time changes in the position of breast cancer cells caused by human tissue flexibility, and shows the video immediately on the affected area to aid the surgeon's attention, reducing the time spent on the surgery.
The new technology has passed performance tests utilizing National Cancer Center-created breast cancer models and animal testing, with medical certification and clinical trials scheduled for the near future.
